Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Sonnet BioTherapeutics Holdings, Inc. Common Stock (SONN)

Pharmaceutical Preparations

https://www.sonnetbio.com

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

100 OVERLOOK CENTER, SUITE 102
PRINCETON, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/01/2020

Market Cap

3,439,379

Shares Outstanding

3,070,000

Weighted SO

3,069,516

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

YS --.--%

ZVSA --.--%

ALLR --.--%

KRBP --.--%

IMMX --.--%

CNSP --.--%

EFTR --.--%

NAVB --.--%

Beta

0.9900

Last Div

0.0000

Range

0.6245-7.7

Chg

-0.1489

Avg Vol

99270

Mkt Cap

3439379

Exch

NASDAQ

Country

US

Phone

609-375-2227

DCF Diff

-1.1857

DCF

1.8108

Div Yield

0.0000

P/S

61.5483

EV Multiple

-0.0029

P/FV

1.2720

Div Yield %

0.0000

P/E

-0.4170

PEG

-0.0047

Payout

0.0000

Current Ratio

1.6489

Quick Ratio

1.6489

Cash Ratio

1.1429

DSO

3393.9559

DIO

0.0000

Op Cycle

3393.9559

DPO

8469.7715

CCC

-5075.8156

Gross Margin

-0.4491

Op Margin

-219.6853

Pretax Margin

-142.8997

Net Margin

-142.8997

Eff Tax Rate

-0.0096

ROA

-1.3776

ROE

-3.9833

ROCE

-4.5688

NI/EBT

1.0000

EBT/EBIT

0.6505

EBIT/Rev

-219.6853

Debt Ratio

0.0259

D/E

0.0574

LT Debt/Cap

0.0256

Total Debt/Cap

0.0543

Int Coverage

-180.6684

CF/Debt

-66.5619

Equity Multi

2.2141

Rec Turnover

0.1075

Pay Turnover

0.0431

Inv Turnover

0.0000

FA Turnover

0.3376

Asset Turnover

0.0096

OCF/Share

-1.9844

FCF/Share

-2.0206

Cash/Share

0.7056

OCF/Sales

-178.8920

FCF/OCF

1.0182

CF Coverage

-66.5619

ST Coverage

-122.8862

CapEx Coverage

-54.9267

Div&CapEx Cov

-54.9267

P/BV

1.2720

P/B

1.2720

P/S

61.5483

P/E

-0.4170

P/FCF

-0.3379

P/OCF

-0.3331

P/CF

-0.3331

PEG

-0.0047

P/S

61.5483

EV Multiple

-0.0029

P/FV

1.2720

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation